Breaking News, Collaborations & Alliances

IBL International, Grifols Partner to Develop Advanced Biomarker Panels

Seek to revolutionize clinical diagnostics with a high-sensitivity, multiplexed immunoassay platform.

Author Image

By: Charlie Sternberg

Associate Editor

IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, has partnered with Grifols, a global healthcare company and producer of plasma-derived medicines and innovative diagnostic solutions, to transform the specialty diagnostics market. Under this collaboration, IBL will develop biomarker panels for specialty diagnostics based on Grifols’ random access, single molecule counting (SMC) platform. These panels will address key customer needs in spec...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters